Former contributor

Brian Laffin

Brian Laffin is a former contributor to the K-Dense blog. Read the article on Clinical Trials, Drug Development, GBM.

Writes about

Posts by Brian Laffin

The GBM Trial Paradox: 1,913 Trials, Zero Breakthrough Approvals
GBM clinical trial analysis: 1,913 trials, yet zero breakthrough approvals. Three insights explain the gap and where glioblastoma research must go next.
January 27, 20262 min read

Back to all posts Meet the K-Dense team